Location History:
- Auenstein, CH (2016)
- Basel, CH (2021)
Company Filing History:
Years Active: 2016-2025
Title: Beat Frei: Innovator in Alzheimer's Disease Treatment
Introduction
Beat Frei is a notable inventor based in Basel, Switzerland, recognized for his contributions to medical science, particularly in the treatment of Alzheimer's disease. With a total of three patents to his name, Frei has made significant strides in developing compounds that target critical pathways associated with neurodegenerative diseases.
Latest Patents
Frei's latest patents include innovative compounds such as 7-phenoxy-N-(3-azabicyclo[3.2.1]octan-8-yl-6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives. These compounds serve as gamma-secretase modulators, which are crucial for treating diseases linked to the deposition of β-amyloid in the brain. The invention outlines the preparation of these compounds, their pharmacological data, and their potential applications in medical treatments for conditions like Alzheimer's disease and related disorders.
Career Highlights
Beat Frei is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work focuses on the development of novel therapeutic agents that can significantly impact the treatment landscape for Alzheimer's and other cognitive disorders.
Collaborations
Frei collaborates with esteemed colleagues such as Luca Claudio Gobbi and Uwe Grether, contributing to a dynamic research environment that fosters innovation and discovery in the field of neuropharmacology.
Conclusion
Beat Frei's innovative work in developing compounds for Alzheimer's treatment highlights his commitment to advancing medical science. His contributions are paving the way for new therapeutic options that could improve the lives of many affected by neurodegenerative diseases.